Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polyvinylpyrrolidone + sodium hyaluronate is a combination of two polymers used primarily as a topical bioadherent gel or solution for mucosal protection. Polyvinylpyrrolidone (PVP) acts as a film-forming agent, while sodium hyaluronate (the salt form of hyaluronic acid) provides lubrication and moisture retention. Together, they form a protective barrier over mucosal surfaces, such as the oral cavity or ocular surface, reducing pain and irritation from conditions like oral mucositis and dry eye syndrome. The combination has been shown to be more effective than either component alone in protecting epithelial tissue and maintaining goblet cell density in preclinical models[1][2][5][7][8]. Its primary mechanism is physical protection via mucoadhesion rather than pharmacological receptor targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyvinylpyrrolidone + sodium hyaluronate.